Switzerland -
A timeline of key events in genetic technologies
What has happened -
September 2018
CRISPR to be used in gene-therapy treatment for patients suffering from β-thalassemia and sickle cell disease.
-
CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in β-thalassemia
-
Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy
-
What is CRISPR-Cas9?